In chronic optic nerve damage conditions, such as glaucoma, the phenomenon of secondary degeneration is less apparent; however, RGC survival in experimental glaucoma was also improved by treatment with minocycline [20, 43, 45] and with the TNFα decoy receptor, Etanercept [46], or in mice lacking the Tnf gene [47]. Here, TNF is linked to glaucoma.